These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12799856)

  • 41. Basic mechanisms of migraine and its acute treatment.
    Edvinsson L; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2012 Dec; 136(3):319-33. PubMed ID: 22939884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.
    Goadsby PJ; Edvinsson L; Ekman R
    Ann Neurol; 1988 Feb; 23(2):193-6. PubMed ID: 2454066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cortical spreading depression and meningeal nociception.
    Carneiro-Nascimento S; Levy D
    Neurobiol Pain; 2022; 11():100091. PubMed ID: 35518782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues.
    Knapp L; Szita B; Kocsis K; Vécsei L; Toldi J
    Drug Des Devel Ther; 2017; 11():27-34. PubMed ID: 28053504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine.
    Levy D; Burstein R; Strassman AM
    Ann Neurol; 2005 Nov; 58(5):698-705. PubMed ID: 16240341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Activation of trigeminal brain stem neurons by chemical stimulation of the dura mater encephali--preparation for studying meningeal nociception in the rat].
    Schepelmann K; Ebersberger A; Pawlak M; Oppmann M; Messlinger K
    Schmerz; 1997 Oct; 11(5):322-7. PubMed ID: 12799803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological migraine provocation: a human model of migraine.
    Ashina M; Hansen JM
    Handb Clin Neurol; 2010; 97():773-9. PubMed ID: 20816469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A voxel-based analysis of brain activity in high-order trigeminal pathway in the rat induced by cortical spreading depression.
    Cui Y; Toyoda H; Sako T; Onoe K; Hayashinaka E; Wada Y; Yokoyama C; Onoe H; Kataoka Y; Watanabe Y
    Neuroimage; 2015 Mar; 108():17-22. PubMed ID: 25536498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathophysiology of medication overuse headache--an update.
    Srikiatkhachorn A; le Grand SM; Supornsilpchai W; Storer RJ
    Headache; 2014 Jan; 54(1):204-10. PubMed ID: 24117004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meningeal brain borders and migraine headache genesis.
    Christensen SL; Levy D
    Trends Neurosci; 2024 Nov; 47(11):918-932. PubMed ID: 39304416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurotransmitters and neuropeptides in headache.
    Limmroth V; Cutrer FM; Moskowitz MA
    Curr Opin Neurol; 1996 Jun; 9(3):206-10. PubMed ID: 8839612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pain-Related Brain Connectivity Changes in Migraine: A Narrative Review and Proof of Concept about Possible Novel Treatments Interference.
    de Tommaso M; Vecchio E; Quitadamo SG; Coppola G; Di Renzo A; Parisi V; Silvestro M; Russo A; Tedeschi G
    Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33668449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of Migraine Headache in Cancer Patients.
    Wolf T; Arnold G
    Curr Rev Pain; 1999; 3(3):206-213. PubMed ID: 10998676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Phytocompounds for Effective Management of Migraine: Current and Future Prospectives.
    Randive S; Sahu SK; Vyas M
    Cent Nerv Syst Agents Med Chem; 2024 Sep; ():. PubMed ID: 39257148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two TRPV1 receptor antagonists are effective in two different experimental models of migraine.
    Meents JE; Hoffmann J; Chaplan SR; Neeb L; Schuh-Hofer S; Wickenden A; Reuter U
    J Headache Pain; 2015; 16():57. PubMed ID: 26109436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Animal models and their results in relation to the therapy of migraine].
    Kaube H; Limmroth V
    Schmerz; 1996 Jun; 10(3):114-20. PubMed ID: 12799856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental migraine models and their relevance in migraine therapy.
    Arulmani U; Gupta S; VanDenBrink AM; Centurión D; Villalón CM; Saxena PR
    Cephalalgia; 2006 Jun; 26(6):642-59. PubMed ID: 16686903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding migraine: Potential role of neurogenic inflammation.
    Malhotra R
    Ann Indian Acad Neurol; 2016; 19(2):175-82. PubMed ID: 27293326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-HT1 receptors in migraine pathophysiology and treatment.
    Ferrari MD; Saxena PR
    Eur J Neurol; 1995 Mar; 2(1):5-21. PubMed ID: 24283575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of calcitonin gene-related peptide in trigeminal ganglion following chronic exposure to paracetamol in a CSD migraine animal model.
    Yisarakun W; Chantong C; Supornsilpchai W; Thongtan T; Srikiatkhachorn A; Reuangwechvorachai P; Maneesri-le Grand S
    Neuropeptides; 2015 Jun; 51():9-16. PubMed ID: 25998753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.